Tag Archives: Novartis

This Explains A Lot

Posted on by

Yesterday Just the News posted an article about the members of the National Institutes of Health’s COVID-19 Treatment Guidelines Panel. It seems as if they have allowed their financial interests to interfere with the interests of the Americans who have contracted the coronavirus.

The article reports:

Members of the National Institutes of Health’s COVID-19 Treatment Guidelines Panel have financial ties to a company behind clinical trials of a drug to treat coronavirus, as well as to another large pharmaceutical company involved with developing a COVID-19 vaccine.

According to the NIH, members of the panel include U.S. physicians, statisticians, and other experts who are developing treatment guidelines on COVID-19 “intended for healthcare providers.”

A total of eight panel members list a financial relationship with Gilead Sciences on the panel’s Financial Disclosure for Companies Related to COVID-19 Treatment or Diagnostics document: Judith Aberg, MD, Adaora Adimora, MD, Jason Baker, MD, Roger Bedimo, MD, Eric Daar, MD, David V. Glidden, PhD, Susanna Naggie, MD, and Pablo Tebas, MD.  

The U.S. has reportedly bought almost all of Gilead Sciences’ supply of the COVID-19 drug remdesivir. The company announced on June 1 the results of a phase 3 clinical trial of the drug in patients with moderate COVID-19.

On Monday, Gilead applied for FDA approval of remdesivir, which has been available for emergency use with patients hospitalized with severe cases of COVID-19.

The article notes:

Dr. William O’Neill, a cardiologist and Medical Director at the Henry Ford Health System in Detroit, Mich., told Just the News contributor Sharyl Attkisson in an interview for her news program “Full Measure” that he is less impressed with remdesivir.

“There is a lot of hype for the drug,” said O’Neil, adding that he sees “no big benefit” to remdesivir after reading medical journal reports on it.  

This appears to be a blatant example of ‘follow the money’ resulting in Americans dying from the coronavirus because of pressure to block using hydroxychloroquine. It should be noted that remdesivir costs thousands of dollars for one pill and hydroxychloroquine costs less than a dollar for one pill. It’s sad to think that doctors would behave so badly, but it appears that they have.

It’s Good To Have A Friend

Posted on by

The Washington Free Beacon reported today that giving money to the Clinton Foundation has many benefits.

The article reports:

Drug companies that have donated to Hillary Clinton’s foundation received most of the contract money from an international tuberculosis initiative after the foundation was brought on to manage the initiative’s procurement operation, public records show.

Two of every three dollars spent acquiring anti-tuberculosis drugs through the program, which is administered by the World Bank, have gone to two companies—Swiss health care giant Novartis and Indian drug company Lupin Ltd.—that together have donated up to $130,000 to the Clinton Foundation.

Clinton and her allies have pointed to the foundation’s international charitable work to deflect allegations of cronyism. However, the millions of dollars in contracts awarded to the two drug companies illustrate how foundation donors profited from laudable causes.

The article also points out:

Clinton has pointed to her foundation’s work in promoting access to pharmaceuticals in the developing world as an example of its laudatory humanitarian mission.

However, critics have noted how beneficiaries of other foundation-backed pharmaceutical access programs have made large financial contributions to the group. Companies that received funds from the foundation to provide low-cost HIV drugs, for instance, were donors to the foundation.

In many cases, the same companies were also lobbying the State Department for lucrative international health contracts while Clinton was secretary of state.

Despite years of collaboration with the industry, Clinton has described pharmaceutical companies as her “enemies,” even as lobbyists for the industry bankroll her presidential campaign.

Unfortunately, this kind of corruption has been going on with the Clintons for a very long time. It needs to end. If she is elected, the Clinton Administration will be a money-making scheme to enrich the Clintons while ignoring the problems and needs of America.